Subscribe to RSS
DOI: 10.1055/s-0030-1258258
Limitations of the ‘Two-Phase’ Doebner-Miller Reaction for the Synthesis of Quinolines
Publication History
Publication Date:
17 September 2010 (online)
Abstract
The Doebner-Miller synthesis of quinolines under modified biphasic conditions was investigated. Crotonaldehyde, reacted readily with aniline to produce 2-methylquinoline. However, cinnamaldehyde and other γ-substituted α,β-unsaturated aldehydes yielded complex mixtures with substituted anilines to provide only trace quantities of quinolines. The Doebner-Miller reaction under these conditions is only suitable for sterically accessible α,β-unsaturated aldehydes.
Key words
α,β-unsaturated aldehyde - aniline - quinoline - Doebner-Miller reaction - heterocycle
Quinoline rings feature in a variety of naturally occurring and medicinally active compounds, [¹] [²] including metabolites derived from various flora and fauna. [³] These compounds exhibit a broad range of antimicrobial, [4] antitubercular, [5] antimalarial, [¹] [6] antiallergic, [7] and antiasthmatic activity. [8]
The Doebner-Miller reaction between aromatic amines and α,β-unsaturated carbonyl compounds is regarded as a relatively general method for synthesizing quinolines from readily available starting materials (Scheme [¹] ). [8] The mechanism is complex [9] and dependent on reagents and reaction conditions, but generally appears to proceed via an initial conjugate attack by the aniline on the Michael acceptor when catalyzed by Brönsted acids under aqueous conditions. Synthetic [8] and mechanistic [9] studies of the Doebner-Miller reaction and the related Skraup reaction have been reviewed elsewhere. [8-¹0]

Scheme 1 Doebner-Miller reaction of aniline and crotonaldehyde (THAB = tetrahexylammonium bromide)
In recent years modification of the Doebner-Miller reaction conditions have included the use of two-phase systems with toluene, [¹¹] other strong acids, such as trifluoroacetic acid, [8] and phase-transfer catalysts. [¹²] Although low yields are sometimes obtained, the easy formation of quinolines from inexpensive starting materials makes this reaction a potentially attractive route. The advantage of the two-phase solvent system is that it decreases polymerization of the aldehyde and makes products easier to isolate. [¹¹] This is particularly true if the acid is a polyoxometallate [¹²] and the reaction is performed with microwave irradiation. However, the latter conditions are still not suitable for highly polymerizable substrates like acrolein and propenals and it is necessary to immobilize the aldehyde on silica. In a quest to develop more general, user-friendly conditions we have examined the two-phase Doebner-Miller reaction with aqueous acid and a range of aldehydes and anilines. This study revealed the narrow range of substrates suitable for this methodology.
The reaction between aniline and cinnamaldehyde (2) under modified Doebner-Miller conditions (toluene, 10 M HCl, THAB, 80-90 ˚C, 2 h) did not yield 2-phenylquinoline (10) (Figures [¹] and [²] ). [¹³] The electron-rich 4-methoxyaniline provided some of quinoline 11 but in low conversion (1.6%). The more electrophilic crotonaldehyde did react with aniline in a moderate yield (40%) (Table [¹] , entry 1) and surprisingly, in a reduced yield with 4-methoxyaniline using this aldehyde (entry 2).
The effect of substitution at the γ-position was explored, with 4-methylpent-2-enal (3), cyclohex-1-ene-1-carbaldehyde (4), and 2-myrtenal (5) under the general conditions (Figure [¹] ). These substrates gave complex mixtures with no identifiable products present; quinolines 12, [¹4] 13, and 14 were not isolated (Figure [²] ). These results are consistent with other examples reported in the literature, where only unsubstituted α,β-unsaturated aldehydes, such as 8 and 9, gave quinolines with aniline [¹5] or substituted anilines [¹6] under similar conditions.
We attempted to obtain aldehyde 19 (Scheme [²] ), where a benzyloxy group would be introduced at the 8-position of the quinoline product. Hydrolysis of 1,1,3,3-tetraethoxypropane (17) followed by treatment with sodium hydroxide gave the sodium salt 18. In an NMR-scale experiment, an equivalent each of 18 and benzyl bromide were shaken and left to react in DMSO-d 6. After 24 hours, conversion of 18 into aldehyde 19 was complete, as determined by ¹H NMR spectroscopic analysis. Attempts to carry out this on a preparative scale of > 1 gram were unsuccessful.
Entry | Aniline | Aldehyde | Conditions | Quinoline | Isolated yield (%) | ||||||||||||||
1 |
![]() |
![]() | 10 M HCl, toluene, THAB,a 80-90˚C, 90 min |
![]() | 40 | ||||||||||||||
2 |
![]() |
![]() | 10 M HCl, toluene, THAB,a 80-90 ˚C, 90 min |
![]() | 8b | ||||||||||||||
3 |
![]() |
![]() | 10 M HCl, toluene, THAB,a 80-90 ˚C, 90 min |
![]() | 7b | ||||||||||||||
4 |
![]() |
![]() | 10 M HCl, toluene, THAB,a 80-90 ˚C, 90 min |
![]() | 23 | ||||||||||||||
5 |
![]() |
![]() | 10 M HCl, toluene, THAB,a 80-90 ˚C, 90 min |
![]() | 16 | ||||||||||||||
6 |
![]() |
![]() | 10 M HCl, toluene, THAB,a 80-90 ˚C, 90 min |
![]() | 57c | ||||||||||||||
7 |
![]() |
![]() | 10 M HCl, toluene, THAB,a 80-90 ˚C, 90 min |
![]() | -d | ||||||||||||||
| |||||||||||||||||||
a THAB = tetrahexylammonium
bromide. b Yield after purification by chromatography. c From ref. 13. d Complex mixture. |

Figure 1
Instead, reaction of aniline with either 2-nitrocinnamaldehyde (6) or 2-methoxycinnamaldehyde (7) under the general conditions gave traces of 2-(2-nitrophenyl)quinoline (15) and a complex mixture not containing quinoline 16, respectively.

Figure 2
The effect of substitution on the aromatic ring of aniline was examined (Table [¹] ). Anilines with electron-donating (4-MeO, 2-Me), electron-withdrawing (4-NO2, 2-CO2H, or 4-CO2H), or halogen (4-Br) groups were reacted with crotonaldehyde under the general conditions (entries 2-7). One literature example [¹³] (entry 6) is included in Table [¹] for comparison. All anilines gave the corresponding substituted quinolines 20-24 in low to moderate yields; compound 25 was not obtained. The purification method provided variations in yield. Therefore, no correlation between the potential influence of electron-donating or electron-withdrawing groups on the aniline and the isolated yield of the quinoline product was apparent.

Scheme 2 Formation of aldehyde 19
In the crude ¹H NMR spectra and in the workups of reactions involving crotonaldehyde significant amounts of polymeric material were observed, and this both lowered product yields and hampered isolation. While some quinoline products could be readily purified by recrystallization (22 and 23), others required multiple chromatography (20 and 21) resulting in some decomposition and low yields.
Steric bulk at the γ-position of the α,β-unsaturated aldehyde prevented the formation of quinolines in the Doebner-Miller reaction. More than one mechanism for the Doebner-Miller reaction has been proposed. [8] [9] Formation of products from a sterically accessible crotonaldehyde lend support to a mechanism invoking conjugate addition of the aniline on the α,β-unsaturated aldehyde Michael acceptor. [8] [9]
In conclusion, the two-phase Doebner-Miller reaction catalyzed with aqueous hydrochloric acid is limited to sterically accessible aldehydes, such as crotonaldehyde. Other sterically hindered aldehyde examples studied resulted in predominant polymerization under these conditions.
All chemicals were commercially available and used without further purification. Substituted aldehyde and aniline derivatives were purchased from Sigma-Aldrich and used as received. The ¹H and ¹³C NMR spectra were obtained using a 300 MHz (Varian Gemini 300) or a 400 MHz (Varian Unity 400) spectrometer in CDCl3. ¹H and ¹³C NMR are referenced to solvent, i.e. CDCl3 (δ = 7.24 and δ = 77.0, respectively). Mass spectra were recorded on a Fisions VG-Platform II spectrometer, using electrospray as the ionization technique with HCO2H-MeCN (4:6). Mass Lynx Version I (IBM) software was used to acquire and process the data. HRMS (ESI) were recorded on a Bruker Daltonix 4.7T FT ion cyclotron resonance mass spectrometer (FTICR MS) fitted with an Apollo ESI source in positive ion or negative ion as stated. All MS samples were prepared as solns in MeOH or MeCN. FTIR spectra were recorded in the range 4000-400cm-¹ on a Perkin-Elmer FTIR 1725X spectrophotometer; spectra were recorded using a KBr disc. Analytical TLC was carried out on Merck precoated aluminum TLC plates coated with silica gel 60 F254 (0.2 mm).
Potassium 3-Oxoprop-1-en-1-olate (18)
1,1,3,3-Tetraethoxypropane (17, 5 g, 22.69 mmol), 1 M HCl (5 mL), and H2O (5 mL) were stirred vigorously at r.t. for 75 min. The resulting homogenous soln was cooled to 0 ˚C and adjusted to pH 10 with 5 M KOH. Acetone (80 mL) was added slowly to the soln until crystals separated. The precipitate was filtered, washed with acetone, and dried at r.t. The salt was dissolved in boiling MeOH, treated with charcoal, and filtered. Solvent was removed in vacuo to give an orange gum; yield: 1.94 g (78%). [¹7]
¹H NMR (400 MHz, CD3OD): δ = 5.23 (t, J = 10, 7.2 Hz, 1 H), 8.61 (d, J = 7.2 Hz, 2 H).
MS (ESI): m/z (%) = 110.50 (100) [M + 1].
3-(Benzyloxy)propenal (19)
Potassium 3-oxoprop-1-en-1-olate (18, 0.5 g, 7.04 mmol), BnBr (0.82 mL, 6.68 mmol), and anhyd DMSO (10 mL) were stirred and the mixture was heated to 40 ˚C for 48 h under an atmosphere of N2. The mixture was quenched with H2O (50 mL) and extracted with Et2O (4 × 40 mL). The combined organic layers were washed with brine (40 mL), dried (anhyd MgSO4), and concentrated in vacuo to give an orange oil as a complex mixture.
¹ H NMR Spectroscopic Study of 3-(Benzyloxy)propenal (19)
Potassium 3-oxoprop-1-en-1-olate (50 mg, 0.704 mmol) and BnBr (83.6 µL, 0.704 mmol) were dissolved in DMSO-d 6 (1 mL) in a 5-mm NMR tube the reaction was mixed and left for 24 h. A ¹H NMR spectrum was obtained.
¹H NMR (400 MHz, DMSO-d 6 ): δ = 5.080 (s, 1 H, H1′), 5.633 (dd, J = 8.4, 4, 8.4 Hz, 1 H, H2′), 7.2-7.5 (m, 5 H, H3′, H7′), 7.932 (d, J = 12.4 Hz, 1 H, H3′), 9.340 [d, J = 8 Hz, 1 H, C(O)H].
MS (ESI): m/z (%) = 163.87 (10) [M + 1].
Quinolines 1, 10, 11, 15, 20-23; General Procedure
A soln of toluene (10 mL), substituted aniline, THAB (5%), and concd HCl (10 M, 40 mL) was heated to 80-90 ˚C. α,β-Unsaturated aldehyde was added slowly and the mixture stirred for 1.5 h. After cooling to r.t., the mixture was neutralized with 2 M NaOH, and the resulting mixture was extracted with CHCl3. The organic layer was washed with brine and dried (anhyd MgSO4), and the solvent was removed in vacuo to afford the crude product. The crude product was either recrystallized (EtOAc-hexane) (22) or purified by column chromatography (silica gel, hexane-EtOAc, 5:1) (1, 10, 11, 15, 20, 21, and 23), and in some cases recrystallized (EtOAc) again (22).
2-Methylquinoline (1)
Following the general procedure using aniline (0.98 mL, 10.74 mmol) and crotonaldehyde (1.78 mL, 21.48 mmol), with purification by chromatography gave a yellow oil; yield: 600 mg (40%).
The ¹H NMR spectrum was consistent with previously reported data. [¹²] [¹8]
2-Phenylquinoline (10)
Following the general procedure using aniline (0.49 mL, 5.36 mmol) and cinnamaldehyde (1.35 mL, 10.73 mmol), with purification by chromatography and recrystallization gave an orange solid; yield: 2 mg (<1%); mp 77-80 ˚C (Lit. [¹6] [¹9] [²0] 67-69 ˚C).
The ¹H NMR spectrum was consistent with previously reported data. [¹9] [²0]
6-Methoxy-2-phenylquinoline (11)
Following the general procedure using 4-methoxyaniline (0.5 g, 4.06 mmol) and cinnamaldehyde (1.03 mL, 8.119 mmol), with purification by chromatography and recrystallization gave an orange solid; yield: 8 mg (<1%); mp 125-126 ˚C (Lit. [²0] [²¹] 129-130 ˚C).
The ¹H NMR spectrum was consistent with previously reported data. [²0] [²¹]
2-(2-Nitrophenyl)quinoline (15)
Following the general procedure using aniline (0.98 mL, 10.74 mmol) and trans-2-nitrocinnamaldehyde (3.80 g, 21.47 mmol) gave a brown solid; yield: 3 mg (<1%); mp 116-117 ˚C (Lit. [²²] 118-119 ˚C)
¹H NMR (400 MHz, CDCl3): δ = 7.53 (d, J = 8.4 Hz, 1 H, H3), 7.55-7.61 (m, 2 H, H6, H5′), 7.70-7.76 (m, 3 H, H7, H4′, H6′), 7.86 (d, J = 6.8 Hz, 1 H, H8), 7.98 (d, J = 9.2 Hz, 1 H, H3′), 8.09 (d, J = 9.6 Hz, 1 H, H5), 8.23 (d, J = 8.4 Hz, 1 H, H4).
¹³C NMR (125 MHz, CDCl3): δ = 120.5, 124.5, 127.0, 127.2, 127.5, 129.3, 129.7, 130.0, 131.6, 132.6, 135.9, 136.8, 147.9, 155.6.
MS (ESI) m/z (%) = 205.68 (100); 250.73 (30) [M + 1].
HRMS: m/z [M + H]+ calcd for C15H11N2O2: 251.0815; found: 251.0823.
6-Methoxy-2-methylquinoline (20)
Following the general procedure using 4-methoxyaniline (0.94 mL, 8.12 mmol) and crotonaldehyde (1.35 mL, 16.24 mmol) gave a brown solid; yield: 106 mg (8%); mp 60-62 ˚C (Lit. [²³] 67-68 ˚C).
The ¹H NMR spectrum was consistent with previously reported data. [²³] [²4]
2,8-Dimethylquinoline (21)
Following the general procedure using 2-methylaniline (0.49 mL, 4.66 mmol) and crotonaldehyde (0.77 mL, 9.33 mmol) gave a yellow oil; yield: 54 mg (7%).
The ¹H NMR spectrum was consistent with previously reported data. [²³]
2-Methyl-6-nitroquinoline (22)
Following the general procedure using 4-nitroaniline (0.5 g, 3.62 mmol) and crotonaldehyde (0.60 mL, 7.24 mmol) gave dark-green crystals; yield: 154 mg (23%); mp 162-164 ˚C (Lit. [²5] 165 ˚C).
The ¹H NMR spectrum was consistent with previously reported data. [²5]
6-Bromo-2-methylquinoline (23)
Following the general procedure using 4-bromoaniline (0.5 g, 2.91 mmol) and crotonaldehyde (0.48 mL, 5.81 mmol) gave red-brown crystals; yield: 48 mg (16%); mp 97-99 ˚C (Lit. [²6] 95-96 ˚C).
IR (KBr): 3048, 1488, 646 cm-¹
¹H NMR (400 MHz, CDCl3): δ = 2.752 (s, 3 H, CH3), 7.319 (d, J = 8.4 Hz, 1 H, H3), 7.754 (d, J = 2.0, 2.0 Hz, 1 H, H4), 7.917 (br s, w ˜7.0 Hz, 1 H, H5), 7.942 (d, J = 2.2 Hz, 1 H, H7), 7.981 (d, J = 8.9 Hz, 1 H, H8)
¹³C NMR (100 MHz, CDCl3): δ = 25.2, 119.4, 122.8, 127.5, 129.4, 130.2, 132.8, 135.2, 146.2, 159.4.
MS (ESI) m/z (%) = 223.73 (100) [M + H]+.
HRMS: m/z [M + H]+ calcd for C10H9Br1N1: 221.9912; found: 221.9902.
- Supporting Information for this article is available online:
- Supporting Information
Acknowledgment
K.A.R. gratefully acknowledges a scholarship from Griffith University.
- 1
Bradley SG.Marciano-Cabral F. Antiparasitic Drugs, In Principles of PharmacologyMunson PL.Mueller RA.Breese GR. Chapman & Hall; New York: 1994. p.100 - 2
Clavier S.Rist O.Hansen S.Gerlach L.-O.Hogberg T.Bergman J. Org. Biomol. Chem. 2003, 1: 4248 - 3a
Michael JP. Nat. Prod. Rep. 2005, 22: 627 - 3b
Michael JP. Nat. Prod. Rep. 2004, 21: 650 - 4a
Glushkov RG.Levshin IB.Marchenko NB.Padeiskaya EN. Khim.-Farmatsevt. Zh. 1984, 18: 1048 - 4b
Hoemann MZ.Kumaravel G.Xie RL.Rossi RF.Meyer S.Sidhu A.Cuny GD.Hauske JR. Bioorg. Med. Chem. Lett. 2000, 10: 2675 - 4c
Wainwright M.Kristiansen JE. Int. J. Antimicrob. Agents 2003, 22: 479 - 5a
Yamashkin SA.Oreshkina EA. Chem. Heterocycl. Compd. 2006, 42: 701 - 5b
Kayukova LA.Praliev KD. Pharm. Chem. J. 2000, 34: 11 - 6a
O’Neill PM.Storr RC.Park BK. Tetrahedron 1998, 54: 4615 - 6b
Fotie J. Anti-Infect. Agents Med. Chem. 2006, 5: 357 - 6c
Egan TJ. Mini-Rev. Med. Chem. 2001, 1: 113 - 7
Kovaleva VL.Shilova EV.Poroikov VV. Pharm. Chem. J. 2003, 37: 293 - 8
Wu Y.Liu L.Li H.Wang D.Chen Y. J. Org. Chem. 2006, 71: 6592 - 9a
Denmark SE.Venkatraman S. J. Org. Chem. 2006, 71: 1668 - 9b
Eisch JJ.Dluzniewski T. J. Org. Chem. 1989, 54: 1269 - 10a
Skraup ZH. Ber. Dtsch. Chem. Ges. 1880, 2086 - 10b
Doebner O.von Miller W. Ber. Dtsch. Chem. Ges. 1883, 2464 - 11
Matsugi M.Tabusa F.Minamikawa J.-I. Tetrahedron Lett. 2000, 41: 8523 - 12
Sivaprasad G.Rajesh R.Perumal PT. Tetrahedron Lett. 2006, 47: 1783 - 13
Li XG.Cheng X.Zhou QL. Synth. Commun. 2002, 32: 2477 - 14a
Sato E. Chem. Pharm. Bull. 1990, 38: 1205 - 14b
Endo T.Saeki S.Hamana M. Chem. Pharm. Bull. 1981, 29: 3105 - 15
Calf GE.Samuel EL. Aust. J. Chem. 1963, 16: 833 - 16
Movassaghi M.Hill MD.Ahmad OK. J. Am. Chem. Soc. 2007, 129: 10096 - 17
Bertz SH.Dabbagh G. J. Org. Chem. 1990, 55: 5161 - 18
O’Murchu C. Synthesis 1989, 880 - 19
Crisp GT.Papadopoulos S. Aust. J. Chem. 1989, 42: 279 - 20
Sangu K.Fuchibe K.Akiyama T. Org. Lett. 2004, 6: 353 - 21
Movassaghi M.Hill MD. J. Am. Chem. Soc. 2006, 128: 4592 - 22a
Le Fevre RJW.Mathur FC. J. Chem. Soc. 1930, 2236 - 22b
Grigos VI.Povarov LS.Mikhailov BM.Zelinskii ND. Izv. Akad. Nauk SSSR, Ser. Khim. 1965, 2163 - 23
Sridharan V.Avendano C.Menendez JC. Tetrahedron 2007, 63: 673 - 24
Choi HY.Srisook E.Jang KS.Chi DY. J. Org. Chem. 2005, 70: 1222 - 25
Tahtaoui C.Guillier F.Klotz P.Galzi J.-L.Hibert M.Ilien B. J. Med. Chem. 2005, 48: 7847 - 26
Acheson RM.Flowerday RF. J. Chem. Soc., Perkin Trans. 1 1975, 394
References
- 1
Bradley SG.Marciano-Cabral F. Antiparasitic Drugs, In Principles of PharmacologyMunson PL.Mueller RA.Breese GR. Chapman & Hall; New York: 1994. p.100 - 2
Clavier S.Rist O.Hansen S.Gerlach L.-O.Hogberg T.Bergman J. Org. Biomol. Chem. 2003, 1: 4248 - 3a
Michael JP. Nat. Prod. Rep. 2005, 22: 627 - 3b
Michael JP. Nat. Prod. Rep. 2004, 21: 650 - 4a
Glushkov RG.Levshin IB.Marchenko NB.Padeiskaya EN. Khim.-Farmatsevt. Zh. 1984, 18: 1048 - 4b
Hoemann MZ.Kumaravel G.Xie RL.Rossi RF.Meyer S.Sidhu A.Cuny GD.Hauske JR. Bioorg. Med. Chem. Lett. 2000, 10: 2675 - 4c
Wainwright M.Kristiansen JE. Int. J. Antimicrob. Agents 2003, 22: 479 - 5a
Yamashkin SA.Oreshkina EA. Chem. Heterocycl. Compd. 2006, 42: 701 - 5b
Kayukova LA.Praliev KD. Pharm. Chem. J. 2000, 34: 11 - 6a
O’Neill PM.Storr RC.Park BK. Tetrahedron 1998, 54: 4615 - 6b
Fotie J. Anti-Infect. Agents Med. Chem. 2006, 5: 357 - 6c
Egan TJ. Mini-Rev. Med. Chem. 2001, 1: 113 - 7
Kovaleva VL.Shilova EV.Poroikov VV. Pharm. Chem. J. 2003, 37: 293 - 8
Wu Y.Liu L.Li H.Wang D.Chen Y. J. Org. Chem. 2006, 71: 6592 - 9a
Denmark SE.Venkatraman S. J. Org. Chem. 2006, 71: 1668 - 9b
Eisch JJ.Dluzniewski T. J. Org. Chem. 1989, 54: 1269 - 10a
Skraup ZH. Ber. Dtsch. Chem. Ges. 1880, 2086 - 10b
Doebner O.von Miller W. Ber. Dtsch. Chem. Ges. 1883, 2464 - 11
Matsugi M.Tabusa F.Minamikawa J.-I. Tetrahedron Lett. 2000, 41: 8523 - 12
Sivaprasad G.Rajesh R.Perumal PT. Tetrahedron Lett. 2006, 47: 1783 - 13
Li XG.Cheng X.Zhou QL. Synth. Commun. 2002, 32: 2477 - 14a
Sato E. Chem. Pharm. Bull. 1990, 38: 1205 - 14b
Endo T.Saeki S.Hamana M. Chem. Pharm. Bull. 1981, 29: 3105 - 15
Calf GE.Samuel EL. Aust. J. Chem. 1963, 16: 833 - 16
Movassaghi M.Hill MD.Ahmad OK. J. Am. Chem. Soc. 2007, 129: 10096 - 17
Bertz SH.Dabbagh G. J. Org. Chem. 1990, 55: 5161 - 18
O’Murchu C. Synthesis 1989, 880 - 19
Crisp GT.Papadopoulos S. Aust. J. Chem. 1989, 42: 279 - 20
Sangu K.Fuchibe K.Akiyama T. Org. Lett. 2004, 6: 353 - 21
Movassaghi M.Hill MD. J. Am. Chem. Soc. 2006, 128: 4592 - 22a
Le Fevre RJW.Mathur FC. J. Chem. Soc. 1930, 2236 - 22b
Grigos VI.Povarov LS.Mikhailov BM.Zelinskii ND. Izv. Akad. Nauk SSSR, Ser. Khim. 1965, 2163 - 23
Sridharan V.Avendano C.Menendez JC. Tetrahedron 2007, 63: 673 - 24
Choi HY.Srisook E.Jang KS.Chi DY. J. Org. Chem. 2005, 70: 1222 - 25
Tahtaoui C.Guillier F.Klotz P.Galzi J.-L.Hibert M.Ilien B. J. Med. Chem. 2005, 48: 7847 - 26
Acheson RM.Flowerday RF. J. Chem. Soc., Perkin Trans. 1 1975, 394
References

Scheme 1 Doebner-Miller reaction of aniline and crotonaldehyde (THAB = tetrahexylammonium bromide)






















Figure 1

Figure 2

Scheme 2 Formation of aldehyde 19